Efemoral Medical Announces Series A1 Funding
- Tuesday, December 13, 2022, 7:04
- Finance
- Add a comment
New funding will support increasing enrollment in its ongoing first-in-human trial, EFEMORAL I LOS ALTOS, Calif., Dec. 13, 2022 /PRNewswire/ — Efemoral Medical, developer of advanced interventional bioresorbable therapies, today announced the closing of its $4.9M preferred Series A1…
About the Author
adminasapcorp has written 41775 stories on this site.